{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:01:35Z","timestamp":1790287295441,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T00:00:00Z","timestamp":1383868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-530","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T16:01:01Z","timestamp":1383926461000},"source":"Crossref","is-referenced-by-count":41,"title":["Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up"],"prefix":"10.1186","volume":"13","author":[{"given":"Tom\u00e1s","family":"Merino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio F","family":"San Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo A","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Bettoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Z\u00fa\u00f1iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelayo","family":"Besa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,8]]},"reference":[{"issue":"1","key":"4162_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62 (1): 10-29. 10.3322\/caac.20138.","journal-title":"CA Cancer J Clin"},{"key":"4162_CR2","volume-title":"Gu\u00eda Cl\u00ednica C\u00e1ncer de Pr\u00f3stata en Personas de 15 a\u00f1os y mas. Serie Gu\u00edas Cl\u00ednicas Minsal N\u00b0 34","author":"Ministerio de Salud","year":"2006","unstructured":"Ministerio de Salud: Gu\u00eda Cl\u00ednica C\u00e1ncer de Pr\u00f3stata en Personas de 15 a\u00f1os y mas. Serie Gu\u00edas Cl\u00ednicas Minsal N\u00b0 34. 2006, Santiago: Minsal, 1","edition":"1"},{"issue":"2","key":"4162_CR3","first-page":"211","volume":"63","author":"D Corti","year":"2002","unstructured":"Corti D: Epidemiolog\u00eda del C\u00e1ncer de Pr\u00f3stata, Provincia de Valdivia, 1990-2000. Rev Chil Uro. 2002, 63 (2): 211-214.","journal-title":"Rev Chil Uro"},{"key":"4162_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4067\/S0034-98872001001100010","volume":"129","author":"R Baechler","year":"2001","unstructured":"Baechler R: Prevalencia del c\u00e1ncer de pr\u00f3stata en la comuna de Talca, VII regi\u00f3n Chile. Rev Med Chile. 2001, 129: 1305-10.","journal-title":"Rev Med Chile"},{"issue":"1","key":"4162_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0360-3016(03)00784-3","volume":"58","author":"PA Kupelian","year":"2004","unstructured":"Kupelian PA: Radical prostatectomy, external beam radiotherapy <72\u00a0Gy, external beam radiotherapy\u2009>\u2009or =72\u00a0Gy, permanent seed implantation, or combined seeds\/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys. 2004, 58 (1): 25-33. 10.1016\/S0360-3016(03)00784-3.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4162_CR6","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/jnci\/djh259","volume":"96","author":"AL Potosky","year":"2004","unstructured":"Potosky AL: Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004, 96: 1358-1367. 10.1093\/jnci\/djh259.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"4162_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"28","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV: Biochemical outcome after prostatectomy external beam radiation therapy or intersticial radiation therapy for clinically localized prostate cancer. JAMA. 1998, 28 (11): 969-976.","journal-title":"JAMA"},{"key":"4162_CR8","volume-title":"Treatments for Localized Prostate Cancer: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation [Internet]","author":"R Chou","year":"2011","unstructured":"Chou R, Dana T, Bougatsos C, et al: Treatments for Localized Prostate Cancer: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation [Internet]. 2011, Rockville (MD): Agency for Healthcare Research and Quality (US), Oct. (Evidence Syntheses, No. 91.) Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK82315\/"},{"issue":"6","key":"4162_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.7326\/0003-4819-148-6-200803180-00209","volume":"148","author":"TJ Wilt","year":"2008","unstructured":"Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL: Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med. 2008, 148 (6): 435-448. 10.7326\/0003-4819-148-6-200803180-00209.","journal-title":"Ann Intern Med"},{"issue":"15","key":"4162_CR10","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1001\/jama.2012.460","volume":"307","author":"NC Sheets","year":"2012","unstructured":"Sheets NC, Goldin GH, Meyer AM, et al: Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA. 2012, 307 (15): 1611-1620. 10.1001\/jama.2012.460.","journal-title":"JAMA"},{"issue":"47","key":"4162_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14470","volume":"14","author":"S Hummel","year":"2010","unstructured":"Hummel S, Simpson EL, Hemingway P, Stevenson MD, Rees A: Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation. Health Technol Assess. 2010, 14 (47): 1-108.","journal-title":"Health Technol Assess"},{"issue":"3","key":"4162_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.7326\/0003-4819-155-3-201108020-00347","volume":"155","author":"RR Bannuru","year":"2011","unstructured":"Bannuru RR, Dvorak T, Obadan N, Yu WW, Patel K, Chung M, Ip S: Comparative evaluation of radiation treatments for clinically localized prostate cancer: an updated systematic review. Ann Intern Med. 2011, 155 (3): 171-178. 10.7326\/0003-4819-155-3-201108020-00347.","journal-title":"Ann Intern Med"},{"key":"4162_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.clon.2012.05.002","volume":"24","author":"G Bauman","year":"2012","unstructured":"Bauman G, Rumble RB, Chen J, Loblawx A, Warde P: Intensity-modulated radiotherapy in the treatment of prostate cancer. Clin Oncol. 2012, 24: 461-473. 10.1016\/j.clon.2012.05.002.","journal-title":"Clin Oncol"},{"issue":"2","key":"4162_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.radonc.2009.09.001","volume":"93","author":"AA Aizer","year":"2009","unstructured":"Aizer AA, Yu JB, Colberg JW, McKeon AM, Decker RH, Peschel RE: Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol. 2009, 93 (2): 185-191. 10.1016\/j.radonc.2009.09.001.","journal-title":"Radiother Oncol"},{"issue":"2","key":"4162_CR15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.6004\/jnccn.2010.0012","volume":"8","author":"J Mohler","year":"2010","unstructured":"Mohler J, Bahnson RR, Boston B, et al: NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw. 2010, 8 (2): 162-200.","journal-title":"J Natl Compr Canc Netw"},{"key":"4162_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB, et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998, 280: 969-975. 10.1001\/jama.280.11.969.","journal-title":"JAMA"},{"issue":"5","key":"4162_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40 (5): 373-383. 10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"key":"4162_CR18","volume-title":"International Commission on Radiation Units and Measurements: ICRU Report 62. Prescribing, Recording and Reporting Photon Beam Therapy","author":"Washigton, DC","year":"1999","unstructured":"Washigton, DC: International Commission on Radiation Units and Measurements: ICRU Report 62. Prescribing, Recording and Reporting Photon Beam Therapy. 1999, Supplement to ICRU Report 50"},{"issue":"4","key":"4162_CR19","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"M Roach 3rd","year":"2006","unstructured":"Roach M, Hanks G, Thames H, Schellhammer P, Shipley WU, Sokol GH, Sandler H: Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference. Int J Radiat Oncol Biol Phys. 2006, 65 (4): 965-974. 10.1016\/j.ijrobp.2006.04.029.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4162_CR20","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1442-2042.2012.03052.x","volume":"19","author":"F Abdollah","year":"2012","unstructured":"Abdollah F, Schmitges J, Sun M, et al: Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis. Int J Urol. 2012, 19: 836-844. 10.1111\/j.1442-2042.2012.03052.x.","journal-title":"Int J Urol"},{"key":"4162_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2407-10-152","volume":"10","author":"MJ Schymura","year":"2010","unstructured":"Schymura MJ, Kahn AR, German RR, et al: Factorseassociated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR patterns of care study. BMC Cancer. 2010, 10: 152-10.1186\/1471-2407-10-152.","journal-title":"BMC Cancer"},{"issue":"5","key":"4162_CR22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ijrobp.2011.11.024","volume":"82","author":"MA Dinan","year":"2012","unstructured":"Dinan MA, Robinson TJ, Zagar TM, Scales CD, Curtis LH, Reed SD, Lee WR, Schulman KA: Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999e2007. Int J Radiation Oncol Biol Phys. 2012, 82 (5): 781-786. 10.1016\/j.ijrobp.2011.11.024.","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"4162_CR23","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.4067\/S0034-98872011001100009","volume":"139","author":"P Besa","year":"2011","unstructured":"Besa P, Rosso R, Bustos M, Borghero Y, Trucco C, Mac-Namara M: Intensity modulated radiotherapy treatment for prostate cancer, first experience in Chile. Rev Med Chile. 2011, 139: 1451-1457. 10.4067\/S0034-98872011001100009.","journal-title":"Rev Med Chile"},{"issue":"1","key":"4162_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/cncr.26272","volume":"118","author":"R Parikh","year":"2012","unstructured":"Parikh R, Sher DJ: Primary radiotherapy versus radical prostatectomy for high-risk prostate cancer: a decision analysis. Cancer. 2012, 118 (1): 258-267. 10.1002\/cncr.26272.","journal-title":"Cancer"},{"issue":"15","key":"4162_CR25","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1200\/JCO.2007.14.9021","volume":"26","author":"EM Horwitz","year":"2008","unstructured":"Horwitz EM, Bae K, Hanks GE, et al: Ten-year follow-up of radiation therapy oncology group protocol 92\u201302: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. J Clin Oncol. 2008, 26 (15): 2497-2504. 10.1200\/JCO.2007.14.9021.","journal-title":"J Clin Oncol"},{"issue":"24","key":"4162_CR26","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","volume":"360","author":"M Bolla","year":"2009","unstructured":"Bolla M, de Reijke TM, Van Tienhoven G, et al: Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med. 2009, 360 (24): 2516-2527. 10.1056\/NEJMoa0810095.","journal-title":"N Engl J Med"},{"issue":"11","key":"4162_CR27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S1470-2045(10)70223-0","volume":"11","author":"M Bolla","year":"2010","unstructured":"Bolla M, Van Tienhoven G, Warde P, et al: External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. Lancet Oncol. 2010, 11 (11): 1066-1073. 10.1016\/S1470-2045(10)70223-0.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4162_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijrobp.2010.11.074","volume":"80","author":"LK Morikawa","year":"2011","unstructured":"Morikawa LK, Roach M: Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions. Int J Radiat Oncol Biol Phys. 2011, 80 (1): 6-16. 10.1016\/j.ijrobp.2010.11.074.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-530\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T01:39:13Z","timestamp":1498095553000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4162"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-530","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,8]]},"article-number":"530"}}